The stent was developed by Gareth Morgan, MD, who oversees the hospital’s interventional congenital cardiology program, according to a May 18 news release from the hospital.
“I am proud to have led the development of the first custom stent approved by the FDA in a decade to treat congenital heart disease,” Dr. Morgan said. “This new stent, in combination with our unmatched imaging technologies, removes significant surgical uncertainties, and is expected to result in improved outcomes for patients of all ages.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
